Tasquinimod is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include tasquinimodum, (N-Methyl-N-(4-trifluoromethyl-phenyl)-1 and 2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide). Its PubChem CID is 54682876.
Tasquinimod
| CAS No | 254964-60-8 |
|---|---|
| Molecular Formula | C20H17F3N2O4 |
| Molecular Weight | 406.4 g/mol |
| Synonyms | 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tasquinimod is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known.
The listed CAS number is 254964-60-8.
The listed molecular formula is C20H17F3N2O4.
The listed molecular weight is 406.4 g/mol.
4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide.
The source lists tasquinimodum, (N-Methyl-N-(4-trifluoromethyl-phenyl)-1 and 2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide).